Singapore Institute of Advanced Medicine Enters Medical Services Agreement With Icon SOC

Singapore Institute of Advanced Medicine (SGX:9G2) entered into a medical service agreement with Icon SOC through its wholly-owned subsidiary, Proton Therapy, according to a filing with the Singapore

MT NewswiresJun 26 23:16 ET

Singapore Institute of Advanced Medicine Receives Listing, Quotation Notice From Singapore Bourse

Singapore Institute of Advanced Medicine (SGX:9G2) received a listing and quotation notice from the Singapore Exchange for the repayment of a loan through the issuance and allotment of 2.5 million sha

MT NewswiresJun 24 00:48 ET

Singapore Institute of Advanced Medicine Forms Strategic Partnership With EnGeneIC

Singapore Institute of Advanced Medicine or SAM (SGX:9G2) signed a strategic partnership with EnGeneIC, giving the company exclusive distribution rights for sales of EDV therapeutics in Asia, a filing

MT NewswiresJun 11 00:37 ET

SAM Holdings Partners With Australia-based EnGeneIC to Bring Latest Cancer Treatment Innovation to Singapore

Yahoo FinanceJun 9 22:15 ET

Singapore Institute of Advanced Medicine Enters Binding Term Sheet With EnGeneIC; Shares Surge 19%

Singapore Institute of Advanced Medicine (SGX:9G2) entered not a binding term sheet with EnGeneIC for the manufacture and distribution of anti-cancer products, according to a filing with the Singapore

MT NewswiresJun 7 01:38 ET

Singapore Institute of Advanced Medicine to Repay Loan Interest Through Share Issuance

Singapore Institute of Advanced Medicine (SGX:9G2) will repay interest accrued on loans procured from Espeetex and Crescendas Land through the allotment and issuance of 2,492,362 shares in the company

MT NewswiresJun 6 01:41 ET